Java (OpenJDK)· ()

Patch todayExploited in the wild (CISA KEV)CISA due 2023-06-02

CVE-2016-3427: Oracle Java SE and JRockit Unspecified Vulnerability

What
Oracle Java SE and JRockit contains an unspecified vulnerability that allows remote attackers to affect confidentiality, integrity, and availability via vectors related to Java Management Extensions (JMX). This vulnerability can be exploited through sandboxed Java Web Start applications and sandboxed Java applets. It can also be exploited by supplying data to APIs in the specified component without using sandboxed Java Web Start applications or sandboxed Java applets, such as through a web service.
Fix
apply the vendor fix or mitigation
Why this tier
Known exploited server software, exploitation is automatable, total technical impact.
Exploited
Yes: 1 CVE in CISA KEV · highest EPSS 92%
Share this

What to do now#

  1. Check whether you run an affected Java (OpenJDK) version:
    java -version
  2. Apply the vendor fix. CISA's required action: Apply updates per vendor instructions.Vendor advisory
  3. Restart JVMs after upgrading; long-running services keep the old runtime loaded. Rebuild container images and jlink'd runtimes, which bundle their own JDK. Oracle JDK, Temurin, Corretto, Zulu and distro OpenJDK all ship the same fixes, each under its own build.
  4. Using distro packages? Distros backport fixes under their own version numbers. Check your distro's status for CVE-2016-3427:Debian · Ubuntu · Red Hat · Alpine
  5. This is exploited in the wild: after patching, check exposed systems for signs of compromise.
  6. Deadline: CISA's federal due date is 2023-06-02. Treat it as the latest reasonable date for everyone else.

CVEs 1#

CVETierCVSSEPSSKEVSSVC exploitation
CVE-2016-3427Patch today9.8 (v3.1)92%Yesactive

Sources#

Built from CISA: Known Exploited Vulnerabilities, checked . Tier from the published rubric.

Also on today's list

See today's list → · Coming up →

Something wrong on this page?
Anonymous. Reports are checked against the primary source.